59651-270 NDC - GLIPIZIDE

Drug Information

  • Product NDC: 59651-270
  • Proprietary Name:
  • Non Proprietary Name: Glipizide
  • Active Ingredient(s): 10 mg/1 GLIPIZIDE
  • Administration Route(s):
  • Dosage Form(s): TABLET, EXTENDED RELEASE

Labeler Information

Field Name Field Value
Labeler Name: Aurobindo Pharma Limited
Product Type: DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category: DRUG FOR FURTHER PROCESSING
Start Marketing Date:5/12/2017
End Marketing Date:11/30/2025

Package Information

No. Package Code Package Description Billing Unit
159651-270-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-270-01)EA
259651-270-05500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-270-05)EA
359651-270-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-270-30)
459651-270-717000 TABLET, EXTENDED RELEASE in 1 BAG (59651-270-71)
559651-270-991000 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-270-99)

NDC Record

Field Name Field Value Definition
PRODUCT NDC59651-270The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE5/12/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEAurobindo Pharma LimitedName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC59651-270The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE5/12/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEAurobindo Pharma LimitedName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code